Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2010-09-20
2011-11-29
Kifle, Bruck (Department: 1622)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
08067437
ABSTRACT:
Compounds of formulain free or salt or solvate form, whereAr is a group of formulaY is carbon or nitrogen and R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, n, p, q and r are as defined in the specification, their preparation and their use as pharmaceuticals, particularly for the treatment of obstructive or inflammatory airways diseases.
REFERENCES:
patent: 5510376 (1996-04-01), Epstein et al.
patent: 5578638 (1996-11-01), Brazzell et al.
patent: 5594027 (1997-01-01), Epstein et al.
patent: 5977154 (1999-11-01), Bell et al.
patent: 0286278 (1988-10-01), None
patent: 0399422 (1990-11-01), None
patent: 0882704 (1997-08-01), None
patent: 0894787 (1997-10-01), None
patent: 1300407 (2003-04-01), None
patent: 03 261755 (1991-11-01), None
patent: 93/18007 (1993-09-01), None
patent: 07002831 (1995-01-01), None
patent: 09501429 (1997-02-01), None
patent: 99/09001 (1999-02-01), None
patent: 2002512639 (2002-04-01), None
patent: WO92/18461 (1992-10-01), None
patent: WO93/15041 (1993-08-01), None
patent: WO 95/04713 (1995-02-01), None
patent: WO 99/51564 (1999-10-01), None
patent: 987425 (1998-08-01), None
Chemical Abstract AN 1994:217308, WO 93/18007, Tsuchiya et al., 1993.
Banitt et al., Monofluoromethanesulfonanilides, A new Series of Bronchodiators, Journal of Medicinal Chemistry, vol. 17, No. 1, 1974.
Eidebenz et al., Ber, vol. 74B, pp. 1798-1801, 1941.
Mitrochkine Anton A et al., “Enantioselective Synthesis of cis- and trans-2(S)-Amino-1-d-indane: Debrominative [1,2]-Hydride Shift Rearrangement by Reduction of cis-2-Azido-1-bromoindane with LiAID4”, J. Org. Chem, vol. 62, pp. 6204-6209, 1997.
Cannon, Joseph G., “Conformationally Restricted Congeners of Dopamine Derived from 2-Aminoindan”, J. Med. Chem., vol. 25, pp. 1442-1446, 1982.
Sindelar et al., “2-Amino-4,7-dimethoxyindan Derivatives: Synthesis and Assessment of Dopaminergic and Cardiovascular Actions”,J. Med. Chem., vol. 25, pp. 858-864, 1982.
Beattie David
Bruce Ian
Cuenoud Bernard
Fairhurst Robin A
Kifle Bruck
McAvoy Cozette M
Novartis AG
LandOfFree
Beta-2-adrenoreceptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Beta-2-adrenoreceptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Beta-2-adrenoreceptor agonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4295299